Age years | ||||
0–2 | 2–4 | 4–6 | >6 | |
Clinical tools | ||||
Symptoms | x | x | x | x |
C-ACT/ACT | - | - | x | x |
ACQ | - | - | - | x |
Exacerbations | x | x | x | x |
QoLQ | - | - | - | x |
Lung function | ||||
Flow–volume curves/BDR | (Tidal) | (Tidal) | (x) | x |
PEF | - | - | (x) | x |
Rint-IOS-FOT | - | x | x | x |
LCI | x | x | x | x |
ILF | x | - | - | - |
BHR | ||||
Direct (methacholine/histamine) | - | - | (x) | x |
Indirect (exercise, mannitol) | x# | x | ||
Inflammatory markers | ||||
FeNO | x | x | x | x |
Induced sputum (eosinophils, LTE4, EPX) | - | - | - | x |
Exhaled breath condensate | - | - | (x) | x |
C-ACT: Childhood Asthma Control Test; ACT: Asthma Control Test; ACQ: Asthma Control Questionnaire; QoLQ: quality of life questionnaire; BDR: bronchodilator response; PEF: peak expiratory flow; Rint; interrupter resistance; IOS: impulse oscillometry; FOT: forced oscillation technique; LCI: lung clearance index; ILF: infant lung function; BHR: bronchial hyperresponsiveness; FeNO: fraction of exhaled nitric oxide; LTE4: leukotriene E4; EPX: eosinophil peroxidase. x: can be used in this age category; (x): might be possible to use in this age group in specialised centres. #: modified exercise challenge possible at preschool age.